U.S. biotech Viking Therapeutics marked itself as a serious competitor in the growing weight loss drug market this week after revealing promising data suggesting its therapy rivals blockbusters from industry giants Novo Nordisk and Eli Lilly. https://go.forbes.com/c/hcfH

#Nostr | #growNostr | #Press | #PLEBchaiN | #Newstr